Roles of Extracellular Vesicles in Multiple Sclerosis: From Pathogenesis to Potential Tools as Biomarkers and Therapeutics

Extracellular vesicles (EVs) are involved in the regulation of immune system functioning and central nervous system (CNS) homeostasis, suggesting a possible role in multiple sclerosis (MS). Indeed, by carrying several types of mediators, such as cytokines, enzymes, and RNAs, EVs can display both anti- and pro-inflammatory roles on the innate and adaptive immune system, and are involved in several CNS functions, including neuronal plasticity, trophic support, disposal of cellular components, axonal maintenance and neuroprotection. In this review, we provide an overview of the studies carried out to understand the role of EVs in the compromised immune system and CNS functioning typical of MS. Moreover, we also highlight the potential of EVs for the diagnosis of this disorder, thanks to their ability to cross the blood-brain barrier (BBB). In addition, we describe the advances in the use of EVs as therapeutic agents by describing their therapeutic potential.

[1]  A. Mannini,et al.  Multiplexing Biosensor for the Detection of Extracellular Vesicles as Biomarkers of Tissue Damage and Recovery after Ischemic Stroke , 2023, International journal of molecular sciences.

[2]  Piotr Szpakowski,et al.  Astrocyte-Derived Exosomes Differentially Shape T Cells’ Immune Response in MS Patients , 2023, International journal of molecular sciences.

[3]  Y-f Han,et al.  Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Jinli Wang,et al.  Exosomal miR-23b-3p from bone mesenchymal stem cells alleviates experimental autoimmune encephalomyelitis by inhibiting microglial pyroptosis , 2023, Experimental Neurology.

[5]  M. Rovaris,et al.  Myelin Basic Protein in Oligodendrocyte-Derived Extracellular Vesicles as a Diagnostic and Prognostic Biomarker in Multiple Sclerosis: A Pilot Study , 2023, International journal of molecular sciences.

[6]  Yonghui Liu,et al.  Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[7]  A. Zalevsky,et al.  Extracellular Vesicles in Chronic Demyelinating Diseases: Prospects in Treatment and Diagnosis of Autoimmune Neurological Disorders , 2022, Life.

[8]  I. Ng,et al.  Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle , 2022, Oncogenesis.

[9]  C. Verderio,et al.  The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after? , 2022, Frontiers in Cellular Neuroscience.

[10]  G. Cheng,et al.  High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination. , 2022, Biomaterials science.

[11]  E. Buzás.  The roles of extracellular vesicles in the immune system , 2022, Nature Reviews Immunology.

[12]  M. A. Di Bella.  Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine , 2022, Biology.

[13]  D. Galimberti,et al.  miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis , 2022, Cells.

[14]  C. Moore,et al.  Analysis of Plasma Using Flow Cytometry Reveals Increased Immune Cell-Derived Extracellular Vesicles in Untreated Relapsing-Remitting Multiple Sclerosis , 2022, Frontiers in Immunology.

[15]  G. Russo,et al.  Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology , 2022, International journal of molecular sciences.

[16]  M. Medalla,et al.  Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system , 2021, Experimental Neurology.

[17]  Jennifer R Linden,et al.  CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis , 2021, Fluids and barriers of the CNS.

[18]  Miou Zhou,et al.  Microglia regulation of synaptic plasticity and learning and memory , 2021, Neural regeneration research.

[19]  L. Kumar,et al.  Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases , 2021, Drug Delivery and Translational Research.

[20]  R. Bălaşa,et al.  Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment , 2021, International journal of molecular sciences.

[21]  C. Baldari,et al.  Differential Proteomic Analysis of Astrocytes and Astrocytes-Derived Extracellular Vesicles from Control and Rai Knockout Mice: Insights into the Mechanisms of Neuroprotection , 2021, International journal of molecular sciences.

[22]  M. Moses,et al.  The role of extracellular vesicles in the physiological and pathological regulation of the blood–brain barrier , 2021, FASEB bioAdvances.

[23]  H. Zetterberg,et al.  The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases , 2021, Journal of Neuroscience Methods.

[24]  Yuan Zhang,et al.  Targeting central nervous system extracellular vesicles enhanced triiodothyronine remyelination effect on experimental autoimmune encephalomyelitis , 2021, Bioactive materials.

[25]  M. J. Wood,et al.  Extracellular vesicles as a next-generation drug delivery platform , 2021, Nature Nanotechnology.

[26]  R. Arnon,et al.  Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions , 2021, International journal of molecular sciences.

[27]  Teresa M. Ribeiro-Rodrigues,et al.  Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading , 2021, Biomolecules.

[28]  Eva-Maria Krämer-Albers,et al.  Extracellular Vesicles in neural cell interaction and CNS homeostasis , 2021, FASEB bioAdvances.

[29]  Santosh Kumar,et al.  Inhibition of extracellular vesicle pathway using neutral sphingomyelinase inhibitors as a neuroprotective treatment for brain injury , 2021, Neural Regeneration Research.

[30]  T. Afonyushkin,et al.  Extracellular vesicles are associated with C-reactive protein in sepsis , 2021, Scientific Reports.

[31]  E. Aikawa,et al.  Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases , 2021, Biomolecules.

[32]  Mengrou Lu,et al.  The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Autoimmune Disorders , 2021, Frontiers in Immunology.

[33]  Z. Salehi,et al.  Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis , 2021, Advanced pharmaceutical bulletin.

[34]  S. Gaudieri,et al.  Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress , 2021, PeerJ.

[35]  T. Malm,et al.  Glia-Derived Extracellular Vesicles: Role in Central Nervous System Communication in Health and Disease , 2021, Frontiers in Cell and Developmental Biology.

[36]  R. Furlan,et al.  Extracellular Vesicles in Neuroinflammation , 2021, Frontiers in Cell and Developmental Biology.

[37]  L. Leocani,et al.  CSF extracellular vesicles and risk of disease activity after a first demyelinating event , 2021, Multiple sclerosis.

[38]  C. Usai,et al.  Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation , 2021, Scientific reports.

[39]  Q. Lu,et al.  Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications , 2021, Frontiers in Immunology.

[40]  S. Haase,et al.  Inflammation in multiple sclerosis , 2021, Therapeutic advances in neurological disorders.

[41]  S. Hashemi,et al.  Intranasal administration of small extracellular vesicles derived from mesenchymal stem cells ameliorated the experimental autoimmune encephalomyelitis. , 2020, International immunopharmacology.

[42]  Hui Yang,et al.  Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases , 2020, Journal of Translational Medicine.

[43]  Hsin-Yao Tang,et al.  Oligodendrocyte-derived extracellular vesicles as antigen-specific therapy for autoimmune neuroinflammation in mice , 2020, Science Translational Medicine.

[44]  S. Du,et al.  Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications , 2020, International journal of nanomedicine.

[45]  R. Scott,et al.  Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls. , 2020, Multiple sclerosis and related disorders.

[46]  P. Bhargava,et al.  Synaptic and complement markers in extracellular vesicles in multiple sclerosis , 2020, Multiple sclerosis.

[47]  W. Banks,et al.  Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.

[48]  David L. Williams,et al.  Novel Role of Endothelial Derived Exosomal HSPA12B in Regulating Macrophage Inflammatory Responses in Polymicrobial Sepsis , 2020, Frontiers in Immunology.

[49]  S. Asgary,et al.  Therapeutic effects of extracellular vesicles from human adipose‐derived mesenchymal stem cells on chronic experimental autoimmune encephalomyelitis , 2020, Journal of cellular physiology.

[50]  Tai-Gyu Kim,et al.  Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis , 2020, Theranostics.

[51]  G. Bitan,et al.  CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges , 2020, Frontiers in Molecular Neuroscience.

[52]  F. Sánchez‐Madrid,et al.  Transfer of extracellular vesicle‐microRNA controls germinal center reaction and antibody production , 2020, EMBO reports.

[53]  G. Bijelic,et al.  MiR-219a-5p Enriched Extracellular Vesicles Induce OPC Differentiation and EAE Improvement More Efficiently Than Liposomes and Polymeric Nanoparticles , 2020, Pharmaceutics.

[54]  L. O’Driscoll,et al.  Inhibiting extracellular vesicles formation and release: a review of EV inhibitors , 2019, Journal of extracellular vesicles.

[55]  Aijun Wang,et al.  Placental Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Myelin Regeneration in an Animal Model of Multiple Sclerosis , 2019, Cells.

[56]  M. Vidal.  Exosomes: Revisiting their role as “garbage bags” , 2019, Traffic.

[57]  Qingbo Xu,et al.  T‐cell–derived extracellular vesicles regulate B‐cell IgG production via pyruvate kinase muscle isozyme 2 , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  D. Ragozzino,et al.  Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission. , 2019, Seminars in cell & developmental biology.

[59]  P. Bhargava,et al.  Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis , 2019, Cells.

[60]  E. Mowry,et al.  Environmental and genetic risk factors for MS: an integrated review , 2019, Annals of clinical and translational neurology.

[61]  M. Onofrj,et al.  Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. , 2019, Journal of proteomics.

[62]  C. Garlanda,et al.  Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure , 2019, Acta Neuropathologica.

[63]  J. Lötvall,et al.  Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders. , 2019, ACS nano.

[64]  M. D’Elios,et al.  A T Cell Suppressive Circuitry Mediated by CD39 and Regulated by ShcC/Rai Is Induced in Astrocytes by Encephalitogenic T Cells , 2019, Front. Immunol..

[65]  E. Bongarzone,et al.  Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis , 2019, Proceedings of the National Academy of Sciences.

[66]  D. Bourdette,et al.  Myelin repair stimulated by CNS-selective thyroid hormone action. , 2019, JCI insight.

[67]  S. M. Taghdisi,et al.  Immunomodulatory properties of MSC‐derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Nicholas J. Carruthers,et al.  Exosome-enriched fractions from MS B cells induce oligodendrocyte death , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[69]  M. Juan,et al.  Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial , 2019, Proceedings of the National Academy of Sciences.

[70]  M. Izad,et al.  Altered Expression of miR-326 in T Cell-derived Exosomes of Patients with Relapsing-remitting Multiple Sclerosis. , 2019, Iranian journal of allergy, asthma, and immunology.

[71]  Xue Yang,et al.  Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. , 2019, International immunopharmacology.

[72]  Y. Koyama,et al.  Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage , 2019, International journal of molecular sciences.

[73]  K. Gilligan,et al.  Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy , 2019, Cancers.

[74]  A. Anel,et al.  Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease , 2018, Cells.

[75]  Junhua Xiao,et al.  Brain-Derived Neurotrophic Factor in Central Nervous System Myelination: A New Mechanism to Promote Myelin Plasticity and Repair , 2018, International journal of molecular sciences.

[76]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[77]  S. Realmuto,et al.  Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid , 2018, Front. Cell. Neurosci..

[78]  Sueli Marques,et al.  Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis , 2018, Nature Medicine.

[79]  N. J. Allen,et al.  Glia as architects of central nervous system formation and function , 2018, Science.

[80]  I. Azoulay-Alfaguter,et al.  Proteomic analysis of human T cell‐derived exosomes reveals differential RAS/MAPK signaling , 2018, European journal of immunology.

[81]  K. Zheng,et al.  Molecular and Genetic Evidence for the PDGFRα-Independent Population of Oligodendrocyte Progenitor Cells in the Developing Mouse Brain , 2018, The Journal of Neuroscience.

[82]  M. Gutiérrez-Fernández,et al.  Therapeutic potential of extracellular vesicles derived from human mesenchymal stem cells in a model of progressive multiple sclerosis , 2018, PloS one.

[83]  G. Martino,et al.  Extracellular Vesicles Containing IL-4 Modulate Neuroinflammation in a Mouse Model of Multiple Sclerosis. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[84]  M. Fernández-Mercado,et al.  The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients , 2018, International journal of molecular sciences.

[85]  K. Lambertsen,et al.  Inflammation leads to distinct populations of extracellular vesicles from microglia , 2018, Journal of Neuroinflammation.

[86]  F. Milagro,et al.  Regulatory roles of miR-155 and let-7b on the expression of inflammation-related genes in THP-1 cells: effects of fatty acids , 2018, Journal of Physiology and Biochemistry.

[87]  G. Constantin,et al.  Nanovesicles from adipose-derived mesenchymal stem cells inhibit T lymphocyte trafficking and ameliorate chronic experimental autoimmune encephalomyelitis , 2018, Scientific Reports.

[88]  R. Lechler,et al.  Regulatory T cell-derived extracellular vesicles modify dendritic cell function , 2018, Scientific Reports.

[89]  K. Selmaj,et al.  Multiple sclerosis: Serum-derived exosomes express myelin proteins , 2018, Multiple sclerosis.

[90]  A. Quattrone,et al.  Exosome‐associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  Haiping Hao,et al.  TNFα and IL-1β modify the miRNA cargo of astrocyte shed extracellular vesicles to regulate neurotrophic signaling in neurons , 2018, Cell Death & Disease.

[92]  H. Lassmann.  Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.

[93]  D. Cojoc,et al.  Glia-to-neuron transfer of miRNAs via extracellular vesicles: a new mechanism underlying inflammation-induced synaptic alterations , 2018, Acta Neuropathologica.

[94]  Takashi Yamamura,et al.  Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis , 2018, Nature Communications.

[95]  I. Zagon,et al.  Multiple Sclerosis: Perspectives in Treatment and Pathogenesis , 2017 .

[96]  M. Barnett,et al.  Exosomal microRNA signatures in multiple sclerosis reflect disease status , 2017, Scientific Reports.

[97]  C. Théry,et al.  Qualitative differences in T‐cell activation by dendritic cell‐derived extracellular vesicle subtypes , 2017, The EMBO journal.

[98]  Joanne L Welton,et al.  Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis , 2017, Journal of extracellular vesicles.

[99]  R. Grasso,et al.  Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production , 2017, Front. Neurol..

[100]  E. Goetzl,et al.  Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes , 2017, Front. Neurosci..

[101]  K. Selmaj,et al.  Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis , 2017, Annals of neurology.

[102]  Jialin C. Zheng,et al.  TNF-α promotes extracellular vesicle release in mouse astrocytes through glutaminase , 2017, Journal of Neuroinflammation.

[103]  A. Zarbock,et al.  Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response , 2016, Nature Communications.

[104]  E. Telemo,et al.  Thymic exosomes promote the final maturation of thymocytes , 2016, Scientific Reports.

[105]  Su-Hyun Kim,et al.  Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[106]  M. D’Elios,et al.  The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis , 2016, The Journal of Immunology.

[107]  R. Zivadinov,et al.  Blood circulating microparticle species in relapsing–remitting and secondary progressive multiple sclerosis. A case–control, cross sectional study with conventional MRI and advanced iron content imaging outcomes , 2015, Journal of the Neurological Sciences.

[108]  R. Petersen,et al.  Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.

[109]  C. Clish,et al.  Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α , 2015, Nature Medicine.

[110]  S. Mathivanan,et al.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers , 2015, Proteomics. Clinical applications.

[111]  E. Telemo,et al.  Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens , 2015, Immunology and cell biology.

[112]  T. Yuan,et al.  Commentary (Changes of Synaptic Plasticity in Multiple Sclerosis) , 2015 .

[113]  F. Antonucci,et al.  Active endocannabinoids are secreted on extracellular membrane vesicles , 2015, EMBO reports.

[114]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[115]  Julie Wheway,et al.  Endothelial Microparticles Interact with and Support the Proliferation of T Cells , 2014, The Journal of Immunology.

[116]  M. Comabella,et al.  Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. , 2014, Biomarkers in medicine.

[117]  Isobel S Okoye,et al.  MicroRNA-Containing T-Regulatory-Cell-Derived Exosomes Suppress Pathogenic T Helper 1 Cells , 2014, Immunity.

[118]  H. Wiendl,et al.  Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice , 2014, Journal of visualized experiments : JoVE.

[119]  D. Otaegui,et al.  Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us? , 2014, Front. Cell. Neurosci..

[120]  S. Amor,et al.  Oligodendrocyte‐microglia cross‐talk in the central nervous system , 2014, Immunology.

[121]  K. Pusic,et al.  IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination , 2014, Journal of Neuroimmunology.

[122]  Y. Torrente,et al.  The involvement of microRNAs in neurodegenerative diseases , 2013, Front. Cell. Neurosci..

[123]  Xuetao Cao,et al.  Exosomes with membrane‐associated TGF‐β1 from gene‐modified dendritic cells inhibit murine EAE independently of MHC restriction , 2013, European journal of immunology.

[124]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[125]  Aaron J. Martin,et al.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis , 2012, Nature Biotechnology.

[126]  A. Hatzigeorgiou,et al.  miRNA Regulons Associated with Synaptic Function , 2012, PloS one.

[127]  A. Vercelli,et al.  Myeloid microvesicles are a marker and therapeutic target for neuroinflammation , 2012, Annals of neurology.

[128]  Moses Rodriguez,et al.  Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis , 2012, PloS one.

[129]  B. Ryffel,et al.  Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. , 2012, Immunity.

[130]  E. Clementi,et al.  Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism , 2012, The EMBO journal.

[131]  E. Huseby,et al.  Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models , 2012, Front. Immun..

[132]  P. Bickford,et al.  CX3CR1 Deficiency Leads to Impairment of Hippocampal Cognitive Function and Synaptic Plasticity , 2011, The Journal of Neuroscience.

[133]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[134]  M. Simons,et al.  Inhibition of Myelin Membrane Sheath Formation by Oligodendrocyte-derived Exosome-like Vesicles* , 2010, The Journal of Biological Chemistry.

[135]  A. Mor,et al.  T Cell-Induced Mast Cell Activation: A Role for Microparticles Released from Activated T Cells , 2010, The Journal of Immunology.

[136]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[137]  E. Clementi,et al.  Acid sphingomyelinase activity triggers microparticle release from glial cells , 2009, The EMBO journal.

[138]  A. Compston,et al.  Multiple sclerosis , 2008, The Lancet.

[139]  A. Minagar,et al.  Evidence of platelet activation in multiple sclerosis , 2008, Journal of Neuroinflammation.

[140]  M. Ballmaier,et al.  Up‐regulation of platelet‐derived growth factor by peripheral‐blood leukocytes during experimental allergic encephalomyelitis , 2008, Journal of neuroscience research.

[141]  S. Tenzer,et al.  Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons? , 2007, Proteomics. Clinical applications.

[142]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[143]  J. Strominger,et al.  Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[144]  C. Théry,et al.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. , 2005, Blood.

[145]  A. Minagar,et al.  Elevated endothelial microparticle—monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes , 2005, Multiple sclerosis.

[146]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[147]  Roland Martin,et al.  Immunology of multiple sclerosis. , 2005, Annual review of immunology.

[148]  L. Calzà,et al.  Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[149]  A. Minagar,et al.  Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. , 2004, Frontiers in bioscience : a journal and virtual library.

[150]  Roland Martin,et al.  Development of biomarkers in multiple sclerosis. , 2004, Brain : a journal of neurology.

[151]  Jacqueline Quandt,et al.  The Beta Chemokines CCL4 and CCL5 Enhance Adhesion of Specific CD4+ T Cell Subsets to Human Brain Endothelial Cells , 2004, Journal of neuropathology and experimental neurology.

[152]  C. Mariash,et al.  Triiodothyronine is a survival factor for developing oligodendrocytes , 2003, Molecular and Cellular Endocrinology.

[153]  C. Théry,et al.  Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes , 2002, Nature Immunology.

[154]  P. Benaroch,et al.  Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. , 2002, International immunology.

[155]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[156]  G. FitzGerald,et al.  Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway* , 1999, The Journal of Biological Chemistry.

[157]  J. Puymirat,et al.  Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone , 1997, Glia.

[158]  S. Pfeiffer,et al.  Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors. , 1993, Developmental biology.

[159]  D. Centonze,et al.  Multiple sclerosis: Inflammation, autoimmunity and plasticity , 2022, Handbook of Clinical Neurology.

[160]  Li-Bin Wang,et al.  Encapsulate Bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects of cuprizone induced demyelinating animal model of multiple sclerosis , 2021, Biomaterials Science.

[161]  C. Cudrici,et al.  Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. , 2006, Journal of rehabilitation research and development.